Old Web
English
Sign In
Acemap
>
authorDetail
>
H.-U. Meier-Kriesche
H.-U. Meier-Kriesche
Bristol-Myers Squibb
Immunology
Belatacept
Medicine
Diabetes mellitus
Immunosuppression
5
Papers
185
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly
2017
American Journal of Transplantation
Flavio Vincenti
G. Blancho
Antoine Durrbach
G. Grannas
J. Grinyo
H.-U. Meier-Kriesche
Martin S. Polinsky
L. Yang
Christian P. Larsen
Show All
Source
Cite
Save
Citations (19)
Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT‐EXT at 7 Years After Transplant
2017
American Journal of Transplantation
Sander Florman
T. Becker
Barbara A. Bresnahan
A. Chevaile Ramos
D. Carvalho
G. Grannas
F. Muehlbacher
Philip J. O'Connell
H.-U. Meier-Kriesche
Christopher P. Larsen
Show All
Source
Cite
Save
Citations (17)
Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study
2016
American Journal of Transplantation
A. Durrbach
José Osmar Medina-Pestana
Sander Florman
M. del Carmen Rial
Lionel Rostaing
D. Kuypers
Arthur J. Matas
Thomas Wekerle
Martin S. Polinsky
H.-U. Meier-Kriesche
S. Munier
J. Grinyo
Show All
Source
Cite
Save
Citations (76)
1